Viewing nowCombinationDuvimet SR Tablet 0.25/50/750mg
Metformin Hydrochloride 750mg · Lobeglitazone Sulfate 0.25mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 202301431 · Approved 2023.05.02
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to assist in blood sugar control for adult patients with type 2 diabetes who are also following dietary and exercise regimens. Particularly, it helps effectively manage blood sugar by combining rosiglitazone, sitagliptin, and metformin. This helps to maintain blood sugar levels stably and contributes to the prevention of complications from diabetes.
For antidiabetic therapy, the recommended dose of this medicine is lobeglitazone sulfate 0.5 mg and sitagliptin 100 mg; the dose of extended-release metformin hydrochloride should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. To maintain its extended-release properties, swallow whole; do not split, crush, grind, or chew. Take 1 tablet of this medicine 0.5/100/1000 mg extended-release tablet once daily. Patients taking this medicine 0.25/50/500 mg, 0.25/50/750 mg, or 0.25/50/1000 mg extended-release tablets should take 2 tablets together once daily. If adequate glycemic control cannot be achieved with metformin and sitagliptin, the starting dose of this medicine should be lobeglitazone sulfate 0.5 mg, sitagliptin 100 mg, and the dose of metformin hydrochloride currently being taken, or an appropriate dose therapeutically equivalent to it. For patients switching from combination therapy with lobeglitazone, sitagliptin, and metformin to this medicine, the dose of this medicine should be the existing dose of each component. For special populations with renal impairment, dose adjustment according to renal function is necessary, and renal function assessment is recommended before treatment and periodically during treatment. No dose adjustment is necessary in patients with mild renal impairment (eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). In patients with moderate renal impairment (CKD stage 3A, eGFR ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2), this medicine may be used with adjustment of the metformin hydrochloride dose if it is well tolerated and there is no risk of lactic acidosis; however, the starting dose of extended-release metformin hydrochloride is 500mg or 750mg once daily, and treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. If renal function is below 45 mL/min, treatment should be discontinued immediately.
This medication contains ingredients that can put a strain on the heart, so it should not be used by patients with heart failure or impaired heart function. During treatment, it is important to monitor carefully for symptoms of heart failure such as shortness of breath or swelling, and if such symptoms occur, consult a physician immediately. Additionally, this medication may carry a risk of inducing pancreatitis, so if sudden abdominal pain or vomiting occurs, immediate medical attention should be sought. One of the ingredients in this medication can rarely cause severe allergic reactions, so if symptoms such as hives, rash, or difficulty breathing appear, discontinue use and seek medical attention. It is safe not to use this medication for patients with significantly reduced kidney function or poor liver function, and it is important to conduct kidney and liver function tests before administration. Hypoglycemic symptoms can occur during treatment, so patients should not skip meals, and if hypoglycemic symptoms are suspected, blood sugar should be checked and appropriate actions taken. This medication can cause gastrointestinal disturbances, and initially, symptoms such as nausea, vomiting, and diarrhea may appear; however, these generally improve over time. Excessive alcohol consumption during treatment may increase the risk of side effects from the medication, so it is advisable to avoid drinking. Furthermore, this medication may cause weight gain and edema, so if patients notice sudden weight increases or feelings of swelling, they should inform their physician. Women who are pregnant or planning to become pregnant should definitely consult their physician before taking this medication. In particular, premenopausal women should consider the possibility of pregnancy and take appropriate contraceptive measures. If a surgery is planned or if there is a sudden serious illness, it may be necessary to discuss temporarily discontinuing this medication with a physician. This medication can interact with other drugs, so if patients are taking any other medications, they must inform their physician or pharmacist. Patients should adhere to the prescribed dosage and administration guidelines, and be careful not to double the dose at the next administration if a dose is missed. Regular monitoring of blood sugar and liver, kidney function is essential, and if any abnormal symptoms occur, consulting healthcare professionals immediately is safe.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius. Storing it this way helps to preserve the medication’s effectiveness.
Light blue, oval-shaped film-coated sustained-release tablets with both sides convex
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 750mg · Lobeglitazone Sulfate 0.25mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Lobeglitazone Sulfate 0.5mg +1 more
Tablet · Prescription medication · Combination
JongKundang Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Lobeglitazone Sulfate 0.25mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Lobeglitazone Sulfate 0.25mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.